Pittsburgh, PA, United States of America

David J Hackam

This inventor holds 13 USPTO granted patents and 3 published patent applications, primarily in Inflammatory Disorders. Top assignees: University of Pittsburgh, Johns Hopkins University. Active years: 2012-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Hackam. Retrieved from https://idiyas.com/inventor/david-j-hackam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 69.2

Average Co-Inventor Count = 1.9

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • Pittsburgh, PA (US) (2012 - 2021)
  • Baltimore, MD (US) (2017 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Areas of Expertise:
Aryl Hydrocarbon Receptor
TLR4 Inhibitors
Inflammatory Disorders
Necrotizing Enterocolitis
TLR9 Agonists
Nuclear Oligomerization Domain-2
Gap Junction-Enhancing Agents
Oral Therapy
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David J Hackam

Introduction

David J Hackam is a prominent inventor based in Pittsburgh, PA, known for his significant contributions to the field of medical research and treatment. With a total of 13 patents to his name, Hackam has focused on developing innovative solutions for inflammatory disorders, particularly in vulnerable populations such as premature infants.

Latest Patents

Among his latest patents, Hackam has developed Aryl hydrocarbon receptor (AhR) agonists aimed at preventing and treating inflammatory disorders. This invention specifically addresses the treatment of necrotizing enterocolitis in premature infants, a serious condition that can lead to severe complications. Additionally, he has created compositions and methods for treating infectious, inflammatory, and post-traumatic disorders by utilizing compounds with TLR4 inhibitory activity. These advancements not only provide new treatment methods but also include pharmaceutical compositions that enhance the efficacy of these compounds.

Career Highlights

Hackam has had a distinguished career, working at esteemed institutions such as the University of Pittsburgh and The Johns Hopkins University. His research has significantly impacted the understanding and treatment of various inflammatory conditions, showcasing his dedication to improving patient outcomes.

Collaborations

Throughout his career, Hackam has collaborated with notable colleagues, including Peter Wipf and Matthew D Neal. These partnerships have fostered a collaborative environment that has led to groundbreaking research and innovative solutions in the medical field.

Conclusion

David J Hackam's contributions to medical research and his innovative patents highlight his commitment to advancing treatment options for inflammatory disorders. His work continues to inspire future research and development in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…